Imricor Medical Systems

Imricor Medical Systems is a commercial-stage medical device company leading the development of interventional cardiac magnetic resonance (iCMR) technology for the treatment of cardiac arrhythmias. Its proprietary platform includes the only FDA-cleared iCMR ablation and diagnostic catheters, a compatible electrophysiology recorder/stimulator, and the NorthStar 3D mapping system, designed to work inside an active MRI. The company aims to transform cardiac ablation by offering real-time, radiation-free visualization of soft tissue and direct visualization of lesion formation. Recent FDA clearances for key system components position Imricor to drive adoption of this next-generation procedural approach.

Integrated interventional Cardiac Magnetic Resonance (iCMR) platform for real-time, MRI-guided cardiac ablation procedures. Includes MRI-conditional ablation/diagnostic catheters, EP recorder/stimulator, and 3D mapping software.

Imricor is currently the first and only company with a commercially available, fully integrated iCMR ablation system, giving it a monopoly in this niche. However, it competes indirectly with the entire traditional cardiac ablation ecosystem dominated by giants like Abbott, Johnson & Johnson, Medtronic, and Boston Scientific, whose conventional fluoroscopy-based systems are the entrenched standard of care.